Dow Down 0.17% Nasdaq Down 0.28%

InterMune, Inc. (ITMN)

-NasdaqGS
73.89 0.00(0.00%) Sep 26
Prev Close:73.89
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:65.73
Beta:3.61
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:N/A - N/A
52wk Range:10.95 - 74.24
Volume:0
Avg Vol (3m):3,766,190
Market Cap:7.98B
P/E (ttm):N/A
EPS (ttm):-2.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ITMN

Comparison

Symbol% ChgMkt Cap
ITMN 0.00%7.98B
GILDDown 0.99%160.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):71.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.70
Quarterly EPS Est (Sep-14) :-0.66
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

InterMune, Inc., a biotechnology company, focuses on the research, development, and commercialization of therapies for pulmonology and orphan fibrotic diseases in North America and Europe. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback